JPWO2021160602A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021160602A5
JPWO2021160602A5 JP2022548400A JP2022548400A JPWO2021160602A5 JP WO2021160602 A5 JPWO2021160602 A5 JP WO2021160602A5 JP 2022548400 A JP2022548400 A JP 2022548400A JP 2022548400 A JP2022548400 A JP 2022548400A JP WO2021160602 A5 JPWO2021160602 A5 JP WO2021160602A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512729A (ja
JP7795466B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/053062 external-priority patent/WO2021160602A1/en
Publication of JP2023512729A publication Critical patent/JP2023512729A/ja
Publication of JPWO2021160602A5 publication Critical patent/JPWO2021160602A5/ja
Application granted granted Critical
Publication of JP7795466B2 publication Critical patent/JP7795466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548400A 2020-02-10 2021-02-09 モノアシルグリセロールリパーゼ調節因子 Active JP7795466B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062972484P 2020-02-10 2020-02-10
US62/972,484 2020-02-10
PCT/EP2021/053062 WO2021160602A1 (en) 2020-02-10 2021-02-09 Monoacylglycerol lipase modulators

Publications (3)

Publication Number Publication Date
JP2023512729A JP2023512729A (ja) 2023-03-28
JPWO2021160602A5 true JPWO2021160602A5 (enExample) 2024-02-20
JP7795466B2 JP7795466B2 (ja) 2026-01-07

Family

ID=74595268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548400A Active JP7795466B2 (ja) 2020-02-10 2021-02-09 モノアシルグリセロールリパーゼ調節因子

Country Status (22)

Country Link
US (2) US11708359B2 (enExample)
EP (1) EP4103557B1 (enExample)
JP (1) JP7795466B2 (enExample)
KR (1) KR20220140581A (enExample)
CN (1) CN115066422B (enExample)
AR (1) AR121296A1 (enExample)
AU (1) AU2021220539A1 (enExample)
BR (1) BR112022015116A2 (enExample)
CA (1) CA3169988A1 (enExample)
CL (1) CL2022002136A1 (enExample)
CO (1) CO2022011275A2 (enExample)
CR (1) CR20220376A (enExample)
DO (1) DOP2022000162A (enExample)
EC (1) ECSP22062460A (enExample)
IL (1) IL295447A (enExample)
JO (1) JOP20220180A1 (enExample)
MX (1) MX2022009804A (enExample)
PE (1) PE20221576A1 (enExample)
PH (1) PH12022552019A1 (enExample)
TW (1) TW202140465A (enExample)
UY (1) UY39066A (enExample)
WO (1) WO2021160602A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220140581A (ko) 2020-02-10 2022-10-18 얀센 파마슈티카 엔.브이. 모노아실글리세롤 리파아제 조절제
BR112022019178A2 (pt) 2020-03-26 2022-11-01 Janssen Pharmaceutica Nv Aminociclobutanos como moduladores da monoacilglicerol lipase
BR112022019211A2 (pt) * 2020-03-26 2023-03-07 Janssen Pharmaceutica Nv Azaspirociclos como moduladores de lipase de monoacilglicerol
JP7729832B2 (ja) 2020-03-26 2025-08-26 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ調節因子としてのアリールピペリジン
US12115154B2 (en) 2020-12-16 2024-10-15 Srx Cardio, Llc Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
JP2024532740A (ja) 2021-08-09 2024-09-10 ヤンセン ファーマシューティカ エヌ.ベー. 自閉症スペクトラム障害に使用するためのモノアシルグリセロールリパーゼ調節因子
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003244649A1 (en) 2002-07-25 2004-02-23 Pharmacia Italia Spa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
EP2760450A1 (en) 2011-09-30 2014-08-06 Janssen Pharmaceutica, N.V. Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
JP6832342B2 (ja) 2016-03-31 2021-02-24 武田薬品工業株式会社 複素環化合物
EA036637B1 (ru) 2016-03-31 2020-12-02 Такеда Фармасьютикал Компани Лимитед Гетероциклические спиросоединения, ингибирующие моноацилглицерин-липазу
GB201613163D0 (en) 2016-07-29 2016-09-14 Autifony Therapeutics Ltd Novel compounds
EP3689879B1 (en) 2017-09-29 2025-02-12 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2020211798A1 (zh) 2019-04-16 2020-10-22 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
KR20220140581A (ko) * 2020-02-10 2022-10-18 얀센 파마슈티카 엔.브이. 모노아실글리세롤 리파아제 조절제
BR112022019178A2 (pt) 2020-03-26 2022-11-01 Janssen Pharmaceutica Nv Aminociclobutanos como moduladores da monoacilglicerol lipase
BR112022019211A2 (pt) 2020-03-26 2023-03-07 Janssen Pharmaceutica Nv Azaspirociclos como moduladores de lipase de monoacilglicerol
JP7729832B2 (ja) 2020-03-26 2025-08-26 ヤンセン ファーマシューティカ エヌ.ベー. モノアシルグリセロールリパーゼ調節因子としてのアリールピペリジン

Similar Documents

Publication Publication Date Title
JP2024116190A5 (enExample)
JP2023171775A5 (enExample)
JP2022184985A5 (enExample)
JP2023103258A5 (enExample)
JP2023166402A5 (enExample)
JP2024114921A5 (enExample)
JP2024161376A5 (enExample)
JP2023145572A5 (enExample)
JP2023181322A5 (enExample)
JP2025098156A5 (enExample)
JP2022116141A5 (enExample)
JP2024045126A5 (enExample)
JP2024099716A5 (enExample)
JP2025090801A5 (enExample)
JP2025094038A5 (enExample)
JP2024149687A5 (enExample)
JP2023100857A5 (enExample)
JP2024099585A5 (enExample)
JP2023093656A5 (enExample)
JP2023085264A5 (enExample)
JP2025084821A5 (enExample)
JP2023078173A5 (enExample)
JP2024059782A5 (enExample)
JP2025123368A5 (enExample)
JPWO2021168274A5 (enExample)